[HTML][HTML] Doxorubicin—an agent with multiple mechanisms of anticancer activity

M Kciuk, A Gielecińska, S Mujwar, D Kołat… - Cells, 2023 - mdpi.com
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens
currently in clinical use. However, the precise mechanisms of DOX's action are not fully …

[HTML][HTML] PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment

A Parvez, F Choudhary, P Mudgal, R Khan… - Frontiers in …, 2023 - frontiersin.org
PD-1 (Programmed Cell Death Protein-1) and PD-L1 (Programmed Cell Death Ligand-1)
play a crucial role in regulating the immune system and preventing autoimmunity. Cancer …

Target protein degradation by protacs: A budding cancer treatment strategy

D Choudhary, A Kaur, P Singh, G Chaudhary… - Pharmacology & …, 2023 - Elsevier
Cancer is one of the most common causes of death. So, its lethal effect increases with time.
Near about hundreds of cancers are known in humans. Cancer treatment is done to cure or …

[HTML][HTML] Recent advances in molecular mechanisms of cancer immunotherapy

M Kciuk, EB Yahya, M Mohamed Ibrahim Mohamed… - Cancers, 2023 - mdpi.com
Simple Summary The cancer-immunity cycle is characterized by various stimulatory and
inhibitory factors, which together regulate the immune response and halt the extreme …

[HTML][HTML] Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications

M Kciuk, M Alam, N Ali, S Rashid, P Głowacka… - Molecules, 2023 - mdpi.com
Cellular signaling pathways involved in the maintenance of the equilibrium between cell
proliferation and apoptosis have emerged as rational targets that can be exploited in the …

SMYD2 inhibition–mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity

M Tang, G Chen, B Tu, Z Hu, Y Huang, CC DuFort… - Science …, 2023 - science.org
DNA damage repair (DDR) is a double-edged sword with different roles in cancer
susceptibility and drug resistance. Recent studies suggest that DDR inhibitors affect immune …

[HTML][HTML] Mitochondrial signaling pathways associated with DNA damage responses

T Shimura - International Journal of Molecular Sciences, 2023 - mdpi.com
Under physiological and stress conditions, mitochondria act as a signaling platform to
initiate biological events, establishing communication from the mitochondria to the rest of the …

Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy

S Chauhan, S Jaiswal, V Jakhmola, B Singh… - Cancer Letters, 2024 - Elsevier
The crucial role played by the oncogenic expression of TP53, stemming from mutation or
amyloid formation, in various human malignancies has been extensively studied over the …

[HTML][HTML] Bioactive Compounds of Dietary Origin and Their Influence on Colorectal Cancer as Chemoprevention

P Delgado-Gonzalez, EN Garza-Treviño… - Life, 2023 - mdpi.com
Colorectal cancer (CRC) is one of the most common causes of death and the third most
diagnosed cancer worldwide. The tumor microenvironment and cancer stem cells participate …

N6-methyladenosine reader protein IGF2BP1 suppresses CD8+ T cells-mediated tumor cytotoxicity and apoptosis in colon cancer

Y Peng, Z Zhang, G Yang, Z Dai, X Cai, Z Liu, Q Yun… - Apoptosis, 2024 - Springer
Tumor immune escape is an important manner for colon cancer to escape effective killing by
immune system. Currently, the immune checkpoint PD-1/PD-L1-targeted immunotherapy …